Principal Financial Group Inc Castle Biosciences Inc Transaction History

Principal Financial Group Inc

$167 Billion
Q1 2025

A detailed history of Principal Financial Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 1,467,873 shares of CSTL stock, worth $27.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,467,873

Previous 1,435,665 2.24%

Holding current value

$27.5 Million

Previous $38.3 Million 23.19%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$18.76 - $32.72 $604,222 - $1.05 Million	32,208 Added 2.24%	1,467,873 $29.4 Million
Q4 2024 Jan 31, 2025	BUY	$26.52 - $34.67 $38.1 Million - $49.8 Million	1,435,665 New	1,435,665 $38.3 Million
Q3 2024 Oct 31, 2024	BUY	$17.4 - $31.47 $702,559 - $1.27 Million	40,377 Added 2.7%	1,538,520 $43.9 Million
Q2 2024 Jul 29, 2024	SELL	$18.84 - $24.94 $646,758 - $856,165	-34,329 Reduced 2.24%	1,498,143 $32.6 Million
Q1 2024 Apr 29, 2024	SELL	$18.06 - $25.3 $960,810 - $1.35 Million	-53,201 Reduced 3.36%	1,532,472 $33.9 Million
Q4 2023 Feb 07, 2024	BUY	$12.19 - $22.43 $1.26 Million - $2.32 Million	103,503 Added 6.98%	1,585,673 $34.2 Million
Q3 2023 Nov 02, 2023	BUY	$13.28 - $20.3 $1.62 Million - $2.48 Million	122,169 Added 8.98%	1,482,170 $25 Million
Q2 2023 Aug 07, 2023	BUY	$11.66 - $26.0 $849,477 - $1.89 Million	72,854 Added 5.66%	1,360,001 $18.7 Million
Q1 2023 May 09, 2023	BUY	$19.47 - $28.49 $7.33 Million - $10.7 Million	376,327 Added 41.32%	1,287,147 $29.2 Million
Q4 2022 Feb 09, 2023	BUY	$18.08 - $30.0 $8.59 Million - $14.3 Million	475,080 Added 109.03%	910,820 $21.4 Million
Q3 2022 Nov 09, 2022	BUY	$22.51 - $34.32 $4.19 Million - $6.39 Million	186,064 Added 74.52%	435,740 $11.4 Million
Q2 2022 Aug 10, 2022	BUY	$16.0 - $45.99 $1.16 Million - $3.32 Million	72,226 Added 40.7%	249,676 $5.48 Million
Q1 2022 May 09, 2022	SELL	$33.17 - $46.98 $173,047 - $245,094	-5,217 Reduced 2.86%	177,450 $7.96 Million
Q4 2021 Feb 09, 2022	BUY	$39.06 - $67.58 $501,960 - $868,470	12,851 Added 7.57%	182,667 $7.83 Million
Q3 2021 Nov 09, 2021	BUY	$60.13 - $77.6 $59,468 - $76,746	989 Added 0.59%	169,816 $11.3 Million
Q2 2021 Aug 10, 2021	BUY	$50.07 - $76.78 $4.02 Million - $6.16 Million	80,263 Added 90.63%	168,827 $12.4 Million
Q1 2021 May 10, 2021	BUY	$58.92 - $97.33 $601,691 - $993,933	10,212 Added 13.03%	88,564 $6.06 Million
Q4 2020 Feb 08, 2021	BUY	$43.6 - $73.05 $2.18 Million - $3.66 Million	50,052 Added 176.86%	78,352 $5.26 Million
Q3 2020 Nov 06, 2020	BUY	$38.47 - $52.03 $69,246 - $93,654	1,800 Added 6.79%	28,300 $1.46 Million
Q2 2020 Aug 05, 2020	BUY	$27.28 - $43.01 $722,920 - $1.14 Million	26,500 New	26,500 $999,000

Others Institutions Holding CSTL

# of Institutions

204

Shares Held

26.2M

Call Options Held

128K

Put Options Held

35.4K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $493M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Castle Biosciences Inc Transaction History